Multicenter randomized controlled trial of intensive uric acid lowering therapy for CKD patients with hyperuricemia: TARGET-UA

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Multicenter randomized controlled trial of intensive uric acid lowering therapy for CKD patients with hyperuricemia: TARGET-UA ; day:26 ; month:3 ; year:2024 ; pages:1-9
Clinical and experimental nephrology ; (26.3.2024), 1-9

Creator
Yamamoto, Tetsuya
Kasahara, Masato
Ueshima, Kenji
Uemura, Shiro
Kashihara, Naoki
Kimura, Kenjiro
Konta, Tsuneo
Shoji, Tetsuo
Mima, Akira
Mukoyama, Masashi
Saito, Yoshihiko
Contributor
SpringerLink (Online service)

DOI
10.1007/s10157-024-02483-w
URN
urn:nbn:de:101:1-2406121221553.947143969877
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
10.06.4029, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Yamamoto, Tetsuya
  • Kasahara, Masato
  • Ueshima, Kenji
  • Uemura, Shiro
  • Kashihara, Naoki
  • Kimura, Kenjiro
  • Konta, Tsuneo
  • Shoji, Tetsuo
  • Mima, Akira
  • Mukoyama, Masashi
  • Saito, Yoshihiko
  • SpringerLink (Online service)

Other Objects (12)

Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis

Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis

The association of urinary prostaglandins with uric acid in hyperuricemia patients

The association of urinary prostaglandins with uric acid in hyperuricemia patients

The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD

The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD

Hyperuricemia Facilitates Uric Acid-Mediated Vascular Endothelial Cell Damage by Inhibiting Mitophagy

Hyperuricemia Facilitates Uric Acid-Mediated Vascular Endothelial Cell Damage by Inhibiting Mitophagy

Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health

Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health

Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits

Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits

Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemia

Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemia

Association between urinary uric acid excretion and kidney outcome in patients with CKD

Association between urinary uric acid excretion and kidney outcome in patients with CKD

Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound

Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound

Impact of hyperuricemia on CKD risk beyond genetic predisposition in a population-based cohort study

Impact of hyperuricemia on CKD risk beyond genetic predisposition in a population-based cohort study

Benefits of uric acid-lowering medication after bariatric surgery in patients with gout

Benefits of uric acid-lowering medication after bariatric surgery in patients with gout

Association between serum uric acid, hyperuricemia and periodontitis: a cross-sectional study using NHANES data

Association between serum uric acid, hyperuricemia and periodontitis: a cross-sectional study using NHANES data

Related objects